World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
11682
World Ranking
9391
National Ranking
4141

Andrew P. Mazar publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Andrew P. Mazar sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 232 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Andrew P. Mazar D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew P. Mazar sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Andrew P. Mazar is affiliated with Northwestern University in the United States. Their research primarily lies within the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focus on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine, and Biomedical Engineering.

The main topics covered in Andrew P. Mazar's work include:

  • Wnt/β-catenin signaling in development and cancer
  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Protease and Inhibitor Mechanisms
  • Cancer-related gene regulation
  • Cancer Immunotherapy and Biomarkers

Andrew P. Mazar has published several papers in well-regarded scientific venues. Some recent publications include:

  • Correction: Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-mediated DNA Damage Response, 2021, Clinical Cancer Research
  • uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions, 2020, Bone Research
  • Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  • Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors, 2021, Molecular Imaging and Biology
  • A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma, 2021, European Journal of Cancer

Frequent publication venues for Andrew P. Mazar include:

  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • European Journal of Cancer
  • Molecular Cancer Therapeutics

Their collaboration network features several frequent co-authors, among them:

  • Benedito A. Carneiro
  • Andrey Ugolkov
  • Francis J. Giles
  • Taylor M. Weiskittel
  • Devalingam Mahalingam

Best Publications

  • Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor

    Qing Huai;Andrew P. Mazar;Alice Kuo;Graham C. Parry

  • Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling

    Jose C. Juarez;Mari Manuia;Mark E. Burnett;Oscar Betancourt

  • Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.

    Shafaat A. Rabbani;Andrew P. Mazar;Suzanne M. Bernier;Mahmudul Haq

  • Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion

    Hilary A. Kenny;Chun Yi Chiang;Erin A. White;Elizabeth M. Schryver

  • Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice

    Oliver Stoeltzing;Wenbiao Liu;Niels Reinmuth;Fan Fan

  • Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.

    Robert W. Colman;Robin A. Pixley;Syeda Najamunnisa;Wuyi Yan

  • Urokinase-type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell Interaction

    Takehiko Tarui;Andrew P. Mazar;Douglas B. Cines;Yoshikazu Takada

  • The role of the plasminogen activation system in angiogenesis and metastasis.

    Shafaat A. Rabbani;Andrew P. Mazar

  • The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis.

    Andrew P. Mazar;Jack Henkin;Ronald H. Goldfarb

  • AN AMINO-TERMINAL FRAGMENT OF UROKINASE ISOLATED FROM A PROSTATE CANCER CELL LINE (PC-3) IS MITOGENIC FOR OSTEOBLAST-LIKE CELLS

    Shafast A. Rabbani;Johanne Desjardins;Alexander W. Bell;Denis Banville

  • A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo

    Parisa Khalili;Ani Arakelian;Gaoping Chen;Marian L. Plunkett

  • Targeting SOD1 reduces experimental non–small-cell lung cancer

    Andrea Glasauer;Laura A. Sena;Lauren P. Diebold;Andrew P. Mazar

  • Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours.

    M E Cianfrocca;K A Kimmel;J Gallo;T Cardoso

  • Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met– and Insulin-like Growth Factor-I Receptor–Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice

    Todd W. Bauer;Wenbiao Liu;Fan Fan;Ernest R. Camp

  • Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines.

    Naseema M. Hoosein;Douglas D. Boyd;William J. Hollas;Andrew Mazar

  • Copper Binding by Tetrathiomolybdate Attenuates Angiogenesis and Tumor Cell Proliferation through the Inhibition of Superoxide Dismutase 1

    Jose C. Juarez;Oscar Betancourt;Steven R. Pirie-Shepherd;Xiaojun Guan

  • Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy

    Andrew P. Mazar

  • A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

    Yongjing Guo;Abd Al-Roof Higazi;Ani Arakelian;Bruce S. Sachais

  • Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer

    Amy Walz;Andrey Ugolkov;Sunandana Chandra;Alan Kozikowski

  • Differential Angiogenic Regulation of Experimental Colitis

    John H. Chidlow;Will Langston;James J.M. Greer;Dmitry Ostanin

Frequent Co-Authors

Jack Henkin
Jack Henkin Northwestern University
Douglas B. Cines
Douglas B. Cines University of Pennsylvania
David E. Shaw
David E. Shaw D. E. Shaw Research
Dimitri Coucouvanis
Dimitri Coucouvanis University of Michigan–Ann Arbor
Mingdong Huang
Mingdong Huang Fuzhou University
Douglas D. Boyd
Douglas D. Boyd The University of Texas MD Anderson Cancer Center
Francis J. Giles
Francis J. Giles Northwestern University
Lee M. Ellis
Lee M. Ellis The University of Texas MD Anderson Cancer Center
Bruce Furie
Bruce Furie Beth Israel Deaconess Medical Center
Yoshikazu Takada
Yoshikazu Takada University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Andrew P. Mazar

Trending Scientists

Recently Published Articles